The Directors present their report, together with the financial statements, on the consolidated entity consisting of Traditional Therapy Clinics Limited (ASX:TTC) and the entities it controlled at the end of, or during, the half-year ended 30 June 2017.

The 2017 East Coles Corporate Performance Research has been completed and the Results are in. The Top 10 Finalists from the S&P/ASX100 for the 'Best CEO's' category for 2017 (not in ranked order) are: AGL, ALL, APA, GMG, JHG, MQG, RHC, SEK, TPM, WES.

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network.

The 2017 East Coles Corporate Performance Research has been completed and the Results are in. The Top 10 Finalists from the S&P/ASX100 for the 'Best Companies' category for 2017 (not in ranked order) are: AGL, AMC, APA, BTT, CSL, JHG, RHC, TCL, TPG, WES.

Traditional Therapy Clinics Ltd (ASX:TTC) is pleased to announce the successful completion of the placement to sophisticated investors today to place a total of 5,700,000 ordinary shares in the Company for a total amount of $1,995,000 at a price of $0.35 per share.

Last year some of the Best 'Investment Desirability' stocks in their sectors were AMC, BAP, CSL, GMG, IAG, SEK, TPM and WBC, but which stocks will be the best for 'Investment Desirability' in 2017? Fund managers are able to vote now to determine this year's winners. Voting will be closing down asap.

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has today released its Appendix 4C - Quarterly cash flow report for the period ended 30 June 2017.

Last year some of the Best Boards in their sectors were AMC, CBA, MFG, BXB and SYD, but who will be the Best Boards for 2017? Fund managers are able to vote now to determine this year's winners. Voting will be closing down Friday 28 July.

Oventus Medical Limited (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. Oventus wishes to advise that the closing date for the SPP will be extended from Wednesday 19 July 2017 to Monday 31 July 2017.

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has received FDA 510k clearance for its O2Vent W device, an oral appliance intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnoea.